Editorial: 'Current trends in peptide science'.
- Published in:
- Biopolymers, 2003, v. 71, n. 2, p. 85, doi. 10.1002/bip.10394
- By:
- Publication type:
- Article
Works matching IS 00063525 AND DT 2003 AND VI 71 AND IP 2
Results: 8
1
2
Successful identification of novel agents to control infectious diseases from screening mixture-based peptide combinatorial libraries in complex cell-based bioassays.
- Published in:
- Biopolymers, 2003, v. 71, n. 2, p. 103, doi. 10.1002/bip.10398
- By:
- Publication type:
- Article
3
An autocatalytic reaction as a model for the kinetics of the aggregation of β-amyloid.
- Published in:
- Biopolymers, 2003, v. 71, n. 2, p. 190, doi. 10.1002/bip.10441
- By:
- Publication type:
- Article
4
Oligopeptide inhibition of class I ribonucleotide reductases.
- Published in:
- Biopolymers, 2003, v. 71, n. 2, p. 117, doi. 10.1002/bip.10397
- By:
- Publication type:
- Article
5
Grb2 SH2 domain-binding peptide analogs as potential anticancer agents.
- Published in:
- Biopolymers, 2003, v. 71, n. 2, p. 132, doi. 10.1002/bip.10396
- By:
- Publication type:
- Article
6
Synthetic peptide vaccine and antibody therapeutic development: Prevention and treatment of Pseudomonas aeruginosa.
- Published in:
- Biopolymers, 2003, v. 71, n. 2, p. 141, doi. 10.1002/bip.10395
- By:
- Publication type:
- Article
7
Dmt and opioid peptides: A potent alliance.
- Published in:
- Biopolymers, 2003, v. 71, n. 2, p. 86, doi. 10.1002/bip.10399
- By:
- Publication type:
- Article
8
Homology model of the CB<sub>1</sub> cannabinoid receptor: Sites critical for nonclassical cannabinoid agonist interaction.
- Published in:
- Biopolymers, 2003, v. 71, n. 2, p. 169, doi. 10.1002/bip.10424
- By:
- Publication type:
- Article